About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

KEY TAKEAWAYSWalgreens Boots Alliance shares are sinking in premarket trading, as the pharmacy chain suspends quarterly dividends to shore up its finances while it works to turnaround its business.The company said it needs to conserve cash to cope with legal challenges and refinance its debt.Walgreens shares are trading down more than 10% in premarket trading and have lost around half their value in the past year through Thursday. Walgreens Boots Alliance (WBA) shares are sinking in premarket trading, as th ...

A sign sits in front of a Walgreens store on November 10, 2023 in Wheeling, Illinois. (Photo by ... [+] Scott Olson/Getty Images)Getty ImagesWalgreens Boots Alliance is suspending its quarterly cash dividend as the company works to “evaluate and refine its capital allocation policy" to free up cash for debt financing, litigation needs and to fund the company’s “broader long-term turnaround,” the company said.The drugstore giant, which is already in the early stages of closing more than 1,200 stores, announc ...

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Walgreens and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On Janua ...

No investor likes it when a potential buyout deal for one of their holdings hits a serious roadblock. This is apparently happening to Walgreens Boots Alliance (WBA -4.46%), according to a media report. So, the market aggressively traded out of the pharmacy chain operator's stock on Monday. It fell by nearly 5% in price, a notably steeper decline than the 1.5% dip of the S&P 500 index on the day.A breakdown in talks?CNBC's David Faber reported live and on-air that unnamed sources told him that a looming arra ...

Core Insights - Walgreens (WBA) faced a challenging year in 2024, but its first-quarter results exceeded expectations, leading to initial optimism for 2025 [2][6] - Despite the positive results, analysts remain cautious, with most maintaining "hold" or "sell" ratings on the stock [6] - A recent lawsuit from the Department of Justice has negatively impacted Walgreens' stock, contributing to a decline of over 9% [2][6] Analyst Ratings - Among eight analysts covering Walgreens, four have issued "hold" ratings, three rated it "sell," and only one gave a "buy" rating, with an average price target of $10.81, slightly below the recent closing price of $11.37 [3] - Jefferies and Deutsche Bank analysts have maintained "hold" ratings, expressing the need for more positive data points before expecting a significant turnaround [4] Business Challenges - Analysts highlighted that despite cost-cutting measures, including the closure of hundreds of underperforming stores, Walgreens' retail pharmacy business is likely to continue facing challenges [5] - The new lawsuit from the DOJ adds regulatory risk to Walgreens' already difficult retail environment, as acknowledged by the CEO during the earnings call [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Walgreens Boots Alliance, Inc. due to allegations of materially misleading business information [1] Group 1: Legal Investigation - The investigation is prompted by allegations that Walgreens knowingly filled millions of prescriptions for controlled substances without a legitimate medical purpose from August 2012 to the present [3] - Following the announcement from the U.S. Department of Justice, Walgreens' stock price fell in aftermarket trading on January 17, 2025 [3] Group 2: Class Action Details - Investors who purchased Walgreens securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees or costs due to a contingency fee arrangement [2] - Interested investors can join the class action by submitting a form or contacting the Rosen Law Firm directly [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [4]

Key TakeawaysThe S&P 500 added 0.9% on Tuesday, Jan. 21, the first day of trading following President Donald Trump's return to the White House.Oracle stock surged following reports that the software giant would participate in a massive joint venture to build out AI infrastructure in the U.S.Walgreens shares plunged as the Justice Department filed a lawsuit claiming the pharmacy chain had dispensed prescriptions with no legitimate medical basis. Major U.S. equities indexes advanced as the markets kicked off ...

Key TakeawaysWalgreens Boots Alliance shares tumbled Tuesday after Department of Justice allegations that its pharmacies dispensed prescriptions with no legitimate medical reasoning.The DOJ filed a lawsuit late last week accusing the pharmacy of handing out "millions of unlawful prescriptions" for dangerous opioids, among other drugs.Walgreens said the government is trying to put its pharmacists in a "no-win situation." Walgreens Boots Alliance (WBA) shares sank Tuesday, the first day of trading since the D ...

Shares of Walgreens Boots Alliance (WBA -13.61%) pulled back today after the company again ran into trouble with regulators.On Friday, the Department of Justice (DOJ) filed a lawsuit against Walgreens, alleging that it dispensed "millions of unlawful prescriptions."As of 10:26 a.m. ET, the stock was down 12.7% on the news. Walgreens gets another red flagWalgreens already made a multibillion-dollar settlement over opioid prescriptions two years ago. It agreed to pay $5.7 billion over 15 years, and now it cou ...